Showing results (2561-2570 of 5,264) with videos related to

Sort By:
Pageof 527
Oncology|July 26, 2023
Postoperative Early Body Weight Loss Is a Risk Factor for Recurrence in Patients with pStage III Gastric CancerDaisuke Fujimoto, Keizo Taniguchi, Junpei Takashima, et al.
Oncology|July 11, 2023
The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung CancerNozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, et al.
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Oncology|August 14, 2023
Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with IpilimumabDaniela Angelova-Toshkina, Benjamin Weide, Lutz F Tietze, et al.
Oncology|August 14, 2023
Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims DatabaseHiroaki Ohta, Takeshi Horii, Takeo Yasu
Oncology|August 17, 2023
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing SurveillanceYuko Kanbayashi, Momoko Kobayashi, Miku Anzai, et al.
Oncology|September 4, 2023
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular CarcinomaKazuto Tajiri, Kenichiro Tsukada, Yoshiharu Tokimitsu, et al.
Oncology|August 31, 2023
The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic DrugJan Trøst Jørgensen
Oncology|June 12, 2023
Peripheral Blood-Derived CircVPS35L as a Potential Diagnostic Biomarker for Non-Small Cell Lung CancerNan Liang, Xun Zhang, Luyi Zhang, et al.
Oncology|June 5, 2023
Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based ChemotherapyToshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, et al.
Pageof 527